Kersen(SH:603626) Ge Long Hui A P P·2025-12-08 13:52Core Viewpoint - Company Kosen Technology (603626.SH) announced the sale of its 100% stake in Kosen Medical to Yaolingke for a consideration of 915 million RMB, achieving a value increase of 206.45% [1] Group 1: Transaction Details - The transaction will result in Kosen Technology no longer holding any equity in Kosen Medical, which will be excluded from the company's consolidated financial statements [1] - Kosen Medical, established in July 2018 with a registered capital of 118 million RMB, is a wholly-owned subsidiary primarily engaged in the processing and export of minimally invasive surgical instruments [1] Group 2: Strategic Rationale - The decision to divest Kosen Medical is driven by challenges faced due to external market changes and ongoing Sino-U.S. trade tensions, impacting its business development [1] - Kosen Medical's technology pathways and customer base differ from the core business of Kosen Technology, resulting in limited synergy [1] - The sale aims to optimize the overall asset allocation, divest non-core businesses, focus on the main industry and emerging sectors, and ensure sustainable business development while improving company performance [1] Group 3: Compliance and Transaction Nature - The buyer, Yaolingke, is not a related party of Kosen Technology, and the equity transfer does not constitute a related party transaction according to the Shanghai Stock Exchange listing rules [1]